China Pioneer Pharma Holdings Ltd (1345):企業の財務・戦略的SWOT分析

◆英語タイトル:China Pioneer Pharma Holdings Ltd (1345) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15021
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Pioneer Pharma Holdings Ltd (Pioneer Pharma) is an investment holding company that markets and promotes pharmaceutical products and medical devices. The company offers pharmaceutical products such as anti-inflammatory medicines, pain management, orthopedics, opthalmology, chronic obstructive pulmonary disease, anti-coagulants, anti-asthma; intestinal cleaning agents, ophthalmology, APIs, immune modulators, gastroenterology, gynecological medicines, and cardiac muscle nutraceuticals. Its medical device products comprise wound care systems, ophthalmology instruments, orthopedics, and odontology. Pioneer Pharma’s products serve hospitals, pharmacies and medical institutions nationwide. The company distributes its products through its suppliers located in the US, Italy, Germany, Belgium, China, Ireland, France, Finland, Switzerland and Spain. Pioneer Pharma is headquartered in Shanghai, China.

China Pioneer Pharma Holdings Ltd Key Recent Developments

Jan 01,2019: Change of Directors, resignation of Chief Executive Officer and change of composition of the Board Committees
Aug 24,2018: China Pioneer Pharma Holdings announces Interim results for the six months ended 30 June 2018

This comprehensive SWOT profile of China Pioneer Pharma Holdings Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of China Pioneer Pharma Holdings Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

China Pioneer Pharma Holdings Ltd – Key Information
China Pioneer Pharma Holdings Ltd – Overview
China Pioneer Pharma Holdings Ltd – Key Employees
China Pioneer Pharma Holdings Ltd – Key Employee Biographies
China Pioneer Pharma Holdings Ltd – Key Operational Heads
China Pioneer Pharma Holdings Ltd – Major Products and Services
China Pioneer Pharma Holdings Ltd – History
China Pioneer Pharma Holdings Ltd – Company Statement
China Pioneer Pharma Holdings Ltd – Locations And Subsidiaries
China Pioneer Pharma Holdings Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

China Pioneer Pharma Holdings Ltd – Business Description
China Pioneer Pharma Holdings Ltd – Corporate Strategy
China Pioneer Pharma Holdings Ltd – SWOT Analysis
SWOT Analysis – Overview
China Pioneer Pharma Holdings Ltd – Strengths
China Pioneer Pharma Holdings Ltd – Weaknesses
China Pioneer Pharma Holdings Ltd – Opportunities
China Pioneer Pharma Holdings Ltd – Threats
China Pioneer Pharma Holdings Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

China Pioneer Pharma Holdings Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

China Pioneer Pharma Holdings Ltd, Key Information
China Pioneer Pharma Holdings Ltd, Key Ratios
China Pioneer Pharma Holdings Ltd, Share Data
China Pioneer Pharma Holdings Ltd, Major Products and Services
China Pioneer Pharma Holdings Ltd, History
China Pioneer Pharma Holdings Ltd, Key Employees
China Pioneer Pharma Holdings Ltd, Key Employee Biographies
China Pioneer Pharma Holdings Ltd, Key Operational Heads
China Pioneer Pharma Holdings Ltd, Other Locations
China Pioneer Pharma Holdings Ltd, Subsidiaries
China Pioneer Pharma Holdings Ltd, Key Manufacturing facilities
China Pioneer Pharma Holdings Ltd, Key Competitors
China Pioneer Pharma Holdings Ltd, SWOT Analysis
China Pioneer Pharma Holdings Ltd, Ratios based on current share price
China Pioneer Pharma Holdings Ltd, Annual Ratios
China Pioneer Pharma Holdings Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

China Pioneer Pharma Holdings Ltd, Performance Chart
China Pioneer Pharma Holdings Ltd, Ratio Charts

★海外企業調査レポート[China Pioneer Pharma Holdings Ltd (1345):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiesi USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiesi USA Inc (Chiesi USA), a specialty pharmaceutical company, is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company researches, develops, produces and commercializes innovative products in the areas such as cardiovascular, respiratory, neonatology, rare disease and specia …
  • DJO Finance LLC:企業の戦略的SWOT分析
    DJO Finance LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Mendes Junior Trading E Engenharia SA:企業の戦略・SWOT・財務情報
    Mendes Junior Trading E Engenharia SA - Strategy, SWOT and Corporate Finance Report Summary Mendes Junior Trading E Engenharia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Targovax ASA (TRVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • HeartWare International Inc:企業の製品パイプライン分析2018
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that c …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cellular Biomedicine Group Inc (CBMG):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Grupo Argos SA:企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • AC Immune SA (ACIU):医療機器:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • SANUWAVE Health Inc (SNWV):企業の財務・戦略的SWOT分析
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …
  • Mitsubishi Paper Mills Ltd (38640):企業の財務・戦略的SWOT分析
    Mitsubishi Paper Mills Ltd (38640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Algonquin Power & Utilities Corp:企業の発電所・SWOT分析2018
    Algonquin Power & Utilities Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • The Timken Company
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sanofi SA:企業の戦略・SWOT・財務情報
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析
    TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆